1. Home
  2. AMTX vs AGEN Comparison

AMTX vs AGEN Comparison

Compare AMTX & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aemetis Inc. (DE)

AMTX

Aemetis Inc. (DE)

HOLD

Current Price

$1.96

Market Cap

134.4M

Sector

Industrials

ML Signal

HOLD

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$3.00

Market Cap

147.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMTX
AGEN
Founded
2005
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
134.4M
147.4M
IPO Year
2023
1999

Fundamental Metrics

Financial Performance
Metric
AMTX
AGEN
Price
$1.96
$3.00
Analyst Decision
Strong Buy
Buy
Analyst Count
2
2
Target Price
$12.00
$14.50
AVG Volume (30 Days)
1.1M
581.5K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
32.98
100.00
EPS
N/A
1.02
Revenue
$77,194,000.00
$42,877,086.00
Revenue This Year
$49.77
$107.63
Revenue Next Year
$57.87
N/A
P/E Ratio
N/A
$2.91
Revenue Growth
174.60
89.95
52 Week Low
$1.30
$2.71
52 Week High
$3.80
$7.34

Technical Indicators

Market Signals
Indicator
AMTX
AGEN
Relative Strength Index (RSI) 35.60 38.27
Support Level $1.38 $2.93
Resistance Level $2.25 $3.15
Average True Range (ATR) 0.16 0.22
MACD -0.03 -0.01
Stochastic Oscillator 8.63 11.19

Price Performance

Historical Comparison
AMTX
AGEN

About AMTX Aemetis Inc. (DE)

Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. The operations include California Ethanol, California Dairy Renewable Natural Gas and India Biodiesel. It operates in the reportable geographic segments of North America and India.

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

Share on Social Networks: